Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Chemotherapy Induced Anemia
Interventions: BIOLOGICAL: Sotatercept|DRUG: Placebo
Sponsor: Merck Sharp & Dohme LLC